TD ASSET MANAGEMENT INC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 174 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.61 and the average weighting 0.4%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,295,495
+106.2%
112,030
+100.0%
0.00%
+200.0%
Q2 2023$1,113,018
+62.8%
56,015
+40.3%
0.00%0.0%
Q1 2023$683,744
-17.2%
39,915
-5.4%
0.00%0.0%
Q4 2022$826,148
+77.7%
42,215
+27.3%
0.00%0.0%
Q3 2022$465,000
-49.0%
33,152
-49.9%
0.00%0.0%
Q2 2022$911,000
-13.2%
66,1830.0%0.00%0.0%
Q1 2022$1,050,000
-27.3%
66,1830.0%0.00%0.0%
Q4 2021$1,445,000
-41.7%
66,183
-20.1%
0.00%
-66.7%
Q3 2021$2,477,000
-16.6%
82,8830.0%0.00%0.0%
Q2 2021$2,969,000
-24.8%
82,883
-6.8%
0.00%
-25.0%
Q1 2021$3,946,000
-9.4%
88,933
+12.0%
0.00%
-20.0%
Q4 2020$4,356,000
+207.0%
79,424
+28.0%
0.01%
+150.0%
Q3 2020$1,419,000
+72.8%
62,063
+58.3%
0.00%
+100.0%
Q2 2020$821,000
+50.1%
39,2050.0%0.00%0.0%
Q1 2020$547,000
-50.5%
39,205
-19.2%
0.00%
-50.0%
Q4 2019$1,104,000
+153.8%
48,505
+29.9%
0.00%
+100.0%
Q3 2019$435,000
-0.5%
37,332
+28.1%
0.00%0.0%
Q2 2019$437,000
+4.0%
29,143
+21.6%
0.00%0.0%
Q1 2019$420,000
+12.3%
23,963
-5.1%
0.00%0.0%
Q4 2018$374,000
-25.9%
25,263
+23.3%
0.00%0.0%
Q3 2018$505,000
+25.6%
20,4950.0%0.00%0.0%
Q2 2018$402,000
+6.1%
20,495
+1.5%
0.00%0.0%
Q1 2018$379,00020,1950.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders